CTLLAB.BO · BSE
Clinitech Laboratory Limited
₹35.1
-4.10% (-₹1.5)
Prev. close
₹36.6
Volume
1,200
As of
01 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Clinitech Laboratory Limited
Clinitech Laboratory Limited provides healthcare services in India. The company provides services including pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, and other services. The company was founded in 1990 and is headquartered in Navi Mumbai, India.
Details
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Jagdish Umakant Nayak
Headquarters
Navi Mumbai
Employees
162
Website
ctllab.inExchange
View on BSE ↗Key stats
Market cap
₹8.01 Cr
P/E ratio (TTM)
19.2
EPS (TTM)
₹1.83
Beta (1Y · daily vs NIFTY 50)
0.75
Shares float
8.21 L
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹6.35 Cr | ₹6.40 Cr | ₹8.23 Cr | ₹9.49 Cr | |
| EBITDA | — | ₹1.37 Cr | ₹1.02 Cr | ₹1.05 Cr | ₹1.18 Cr |
| — | ₹61.31 L | ₹37.12 L | ₹39.47 L | ₹41.80 L | |
| Diluted EPS | ₹2.25 | ₹2.69 | ₹1.63 | ₹1.9 | ₹1.83 |
Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹6.03 Cr | ₹5.61 Cr | ₹10.84 Cr | ₹11.18 Cr | |
| — | ₹1.03 Cr | ₹86.31 L | ₹0 | ₹53.75 L | |
| Stockholders' equity | — | ₹2.38 Cr | ₹3.55 Cr | ₹8.83 Cr | ₹9.25 Cr |
Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹1.25 Cr | ₹-1.28 Cr | ₹-87.87 L | ₹-79.26 L | |
| Investing cash flow | ₹-65.32 L | ₹75.36 L | ₹-72.93 L | ₹-68.29 L |
| ₹8.56 L | ₹44.57 L | ₹3.98 Cr | ₹51.30 L | |
| Capital expenditure | ₹-27.97 L | ₹-1.21 Cr | ₹-1.16 Cr | ₹-82.58 L |
| End cash position | ₹78.32 L | ₹70.13 L | ₹3.07 Cr | ₹2.11 Cr |
Debt issued, Debt repaid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| Clinitech Laboratory Limited | ₹8.01 Cr | ₹35.1 | 19.2 | 0.87 | 4.5% | 0.06 | +15.3% | -23.8% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.